Immunotherapy for glioma: Current management and future application

Gliomas are intrinsic brain tumors that originate from neuroglial progenitor cells. Conventional therapies, including surgery, chemotherapy, and radiotherapy, have achieved limited improvements in the prognosis of glioma patients. Immunotherapy, a revolution in cancer treatment, has become a promisi...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cancer letters Ročník 476; s. 1 - 12
Hlavní autoři:	Xu, Shengchao, Tang, Lu, Li, Xizhe, Fan, Fan, Liu, Zhixiong
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Ireland Elsevier B.V 28.04.2020 Elsevier Limited
Témata:	Antibodies Apoptosis Blood-brain barrier Brain cancer Brain Neoplasms - immunology Brain Neoplasms - pathology Brain Neoplasms - therapy Brain tumors Cancer therapies Central nervous system Checkpoint Chemotherapy Clinical trials Cytotoxicity Disease Management FDA approval Glioma Glioma - immunology Glioma - pathology Glioma - therapy Humans Immunotherapy Immunotherapy - methods Ligands Medical prognosis Medical research Melanoma Oncolytic virus Progenitor cells Prognosis Radiation therapy Stem cells Surgery Tumors Vaccine Vascular endothelial growth factor Checkpoint Vaccine Oncolytic virus Glioma Immunotherapy
ISSN:	0304-3835, 1872-7980, 1872-7980
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!